Study for wound healing in HIV-infected patients
Study for wound healing in HIV-infected patients
批准号:
06671185
负责人:
ERIGUCHI Masazumi
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995
中文摘要
本研究旨在建立HIV感染晚期创面愈合能力较差患者的手术指征标准。实验用B6小鼠制备了maid。与对照小鼠相比,maid愈合皮肤切口的断裂强度降低了八分之一。我们试图从接受手术的HIV感染患者的一块皮肤上建立成纤维细胞细胞系,但我们无法建立细胞系。HIV不感染培养的正常成纤维细胞。临床上,我们研究了3例(IV期)腹股沟斜疝修补术和5例(III期:1例,IV期:4例)剖腹手术的伤口愈合延迟。所有病例均需2 ~ 4周创口愈合,无瘢痕疙瘩形成。即使CD4阳性细胞计数低于100/ ml,在HIV感染和HIV指标疾病可控的情况下,伤口也会愈合。根据Montaner分期系统,我们提出hiv感染者的手术指征标准如下:对于第一阶段,评估是根据通常的指标进行的。在第二阶段,应考虑与艾滋病毒有关的发病机制。对于第三阶段和第二阶段,应该进行治疗性手术。对于第四阶段,主要考虑姑息性手术以减轻症状,但如果患者的一般情况良好,则可以进行治疗性手术。
英文摘要
The purpose of this study is to establish the criteria of surgical indications for HIV infected patients whose abillity of wound healing is poor in late stage of HIV infection.Experimentaly we made MAIDS using B6 mouse.The breaking strength of a healing skin incision in the MAIDS was decreased one eighth comparing the strength in a control mouse.We tried to establish cell lines of fibroblast from a piece of skin of HIV infected patients who received operation but we could not established cell lines.HIV did not infect cultured normal fibroblasts.clinically we studied delay of wound healing for 3 patients (stage IV) who received repair of indirect inguinal hernia and for 5 patients (stage III : 1, stage IV : 4) who received laparotomy.In every case, it took 2-4 weeks for healing of wound incision without keloid formation.Even if the cell count of CD4 positive cells was less than 100/mul, wounds would heal on condition that HIV infection and HIV-indicator diseases are controllable.According to Montaner's staging system, we propose criteria for surgical indication for HIV-infected patients as follows.For stage I,assessment is made by the usual indications.In stage II,consideration should be given to HIV-related pathogenesis.For stage III as for stage II,curative operations should be performed.For stage IV,primary consideration is given to palliative operations for alleviating symptoms but if the general condition of the patient is good, a curative operation may be performed.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
江里口正純: "特集/術後管理計画法.AIDS" 外科治療. 72. 949-952 (1995)
Masazumi Eriguchi:“专题/术后管理计划方法。艾滋病”手术治疗。72. 949-952 (1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masazumi Eriguchi: "Surgical indications for HIV infected patients" Biomedicine & Pharmacotherapy. 50. 50- (1996)
Masazumi Eriguchi:“HIV感染者的手术指征” 生物医学
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
江里口正純: "消化器外科とAIDS" 消化器外科. 17. 1937-1944 (1994)
Masazumi Eriguchi:“胃肠外科和艾滋病”胃肠外科。1937-1944(1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masazumi Eriguchi: "Gastroenterological surgery and AIDS" Syoukaki Geka. 17. 1937-1944 (1994)
Masazumi Eriguchi:“胃肠外科和艾滋病”Syoukaki Geka。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Eriguchi: "Surgical Indication for HIV-infected Patients" Biomed.Pharmacother.50. in press (1996)
M.Eriguchi:“HIV 感染患者的手术指征”Biomed.Pharmacother.50。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
Development of molecular targeting therapy using cancer permeabile WOW emulsion by membrane emulfication
-
批准号:18390360
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.42万
-
财政年份:2006
-
负责人:ERIGUCHI Masazumi
-
依托单位:
Development of Molecular Targeting Agents Based on Analysis Oncogenesis with Homeobox Gene Mutation
-
批准号:16390373
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.34万
-
财政年份:2004
-
负责人:ERIGUCHI Masazumi
-
依托单位:
海外基金